(Q44618474)

4 December 2017

Reversal of phencyclidine-induced dopaminergic dysregulation by N-methyl-D-aspartate receptor/glycine-site agonists (English)

1 reference

4 December 2017

Reversal of Phencyclidine-Induced Dopaminergic Dysregulation by N-Methyl-D-Aspartate Receptor/Glycine-site Agonists (English)

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300313

21 March 2024

1 reference

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300313

21 March 2024

1

Daniel C Javitt

1 reference

4 December 2017

Andrea Balla

2

1 reference

4 December 2017

Sarah Burch

3

1 reference

4 December 2017

Ray Suckow

4

1 reference

4 December 2017

Shan Xie

5

1 reference

4 December 2017

Henry Sershen

6

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

full work available at URL

4 December 2017

https://www.nature.com/articles/1300313.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14560321

http://www.nature.com/articles/1300313.pdf

21 March 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300313

http://www.nature.com/articles/1300313

21 March 2024

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300313

21 March 2024

published in

Neuropsychopharmacology

1 reference

4 December 2017

29

1 reference

4 December 2017

2

1 reference

4 December 2017

300-307

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300313

4 December 2017

0 references

cites work

Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Phencyclidine-induced dysregulation of dopamine response to amphetamine in prefrontal cortex and striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Continuous phencyclidine treatment induces schizophrenia-like hyperreactivity of striatal dopamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Modulation of N-methyl-D-aspartate receptor function by glycine transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

The glutamatergic dysfunction hypothesis for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Dopamine in schizophrenia: a review and reconceptualization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Effects of methylphenidate on spatial working memory and planning in healthy young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Cognitive and behavioral effects of the coadministration of dextroamphetamine and haloperidol in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Pharmacological assessment of the role of the glycine transporter GlyT-1 in mediating high-affinity glycine uptake by rat cerebral cortex and cerebellum synaptosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

A.E. Bennett Research Award. Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Non-competitive regulation of phencyclidine/sigma-receptors by the N-methyl-D-aspartate receptor antagonist D-(-)-2-amino-5-phosphonovaleric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

The role of excitatory amino acids in neuropsychiatric illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Amelioration of negative symptoms in schizophrenia by glycine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Altered frontal cortical dopaminergic transmission in monkeys after subchronic phencyclidine exposure: involvement in frontostriatal cognitive deficits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Chronic phencyclidine induces behavioral sensitization and apoptotic cell death in the olfactory and piriform cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Increased dopamine transmission in schizophrenia: relationship to illness phases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Imaging D2 receptor occupancy by endogenous dopamine in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Selective up-regulation of dopamine D1 receptors in dendritic spines by NMDA receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

High dose glycine nutrition affects glial cell morphology in rat hippocampus and cerebellum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Chronic high-dose glycine nutrition: effects on rat brain cell morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Longitudinal assessment of methylphenidate effects on oral word production and symptoms in first-episode schizophrenia at acute and stabilized phases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Antagonism of phencyclidine-induced hyperactivity by glycine in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

D-serine added to antipsychotics for the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

D(1) dopamine receptors potentiate nmda-mediated excitability increase in layer V prefrontal cortical pyramidal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

Functional magnetic resonance imaging of schizophrenic patients and comparison subjects during word production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

ALX 5407: a potent, selective inhibitor of the hGlyT1 glycine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

7 January 2021

Measurement of phencyclidine in saliva

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

7 January 2021

[3H]MK-801 binding to well-washed rat brain membranes following cessation of chronic phencyclidine treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

7 January 2021

Interaction of dopamine D1 and NMDA receptors mediates acute clozapine potentiation of glutamate EPSPs in rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

7 January 2021

D-serine antagonized phencyclidine- and MK-801-induced stereotyped behavior and ataxia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

7 January 2021

The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

7 January 2021

IV glycine and oral D-cycloserine effects on plasma and CSF amino acids in healthy humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

7 January 2021

Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of ventral tegmental area dopamine neurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

7 January 2021

A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

7 January 2021

Glycyldodecylamide, a phencyclidine behavioral antagonist, blocks cortical glycine uptake: implications for schizophrenia and substance abuse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

7 January 2021

Adjunctive high-dose glycine in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

7 January 2021

Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

7 January 2021

Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

7 January 2021

Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

7 January 2021

Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor epsilon1 subunit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

7 January 2021

Glycine and D-serine decrease MK-801-induced hyperactivity in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

7 January 2021

Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300313

7 January 2021

Drug Metabolism and Disposition

57

28

742

JW Proksch

2000

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300313

21 March 2024

Identifiers

1 reference

4 December 2017

1 reference